{"id":"https://openalex.org/W2911758317","doi":"https://doi.org/10.5167/uzh-59269","title":"Bevacizumab in the primary treatment of epithelial ovarian cancer \u2013 some comments on the latest results","display_name":"Bevacizumab in the primary treatment of epithelial ovarian cancer \u2013 some comments on the latest results","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2911758317","doi":"https://doi.org/10.5167/uzh-59269","mag":"2911758317"},"language":"en","primary_location":{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/69873","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/69873","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Achtari, C., Fink, D., G\u00fcnthert, A. R., Huober, J., Pestalozzi, B., Petignat, P., von Moos, R., & Sessa, C. (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer \u2013 some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse Du Cancer, 35, 35\u201338.","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2911758317"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.zora.uzh.ch/handle/20.500.14742/69873","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014722682","display_name":"Chahin Achtari","orcid":"https://orcid.org/0000-0001-9265-9395","observed_orcids":["https://orcid.org/0000-0001-9265-9395"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Achtari, C","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114006726","display_name":"D. Fink","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fink, D","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016486534","display_name":"Andreas R. G\u00fcnthert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G\u00fcnthert, A R","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067146231","display_name":"Jens Huober","orcid":"https://orcid.org/0000-0002-8618-1820","observed_orcids":["https://orcid.org/0000-0002-8618-1820"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huober, J","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082748782","display_name":"BC Pestalozzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pestalozzi, B","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017261148","display_name":"Patrick Petignat","orcid":"https://orcid.org/0000-0002-6835-533X","observed_orcids":["https://orcid.org/0000-0002-6835-533X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petignat, P","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025804381","display_name":"Roger von Moos","orcid":"https://orcid.org/0000-0003-2362-8514","observed_orcids":["https://orcid.org/0000-0003-2362-8514"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"von Moos, R","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5050776115","display_name":"Christiana Sessa","orcid":"https://orcid.org/0009-0008-1294-9738","observed_orcids":["https://orcid.org/0009-0008-1294-9738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sessa, C","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"35","issue":"1","first_page":"35","last_page":"38"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.7319999933242798},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.968999981880188},{"id":"https://openalex.org/keywords/platinum-taxane-chemotherapy","display_name":"platinum-taxane chemotherapy","score":0.6230000257492065},{"id":"https://openalex.org/keywords/optimal-cytoreduction","display_name":"optimal cytoreduction","score":0.7639999985694885},{"id":"https://openalex.org/keywords/postoperative-residual-tumor","display_name":"residual tumor after surgery","score":0.5690000057220459},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9219886064529419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8778483867645264},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.790888786315918},{"id":"https://openalex.org/C2781100745","wikidata":"https://www.wikidata.org/wiki/Q1977435","display_name":"Debulking","level":4,"score":0.7735956907272339},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.61109459400177},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5372130274772644},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5286707878112793},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.519244909286499},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4237365126609802},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.41800814867019653},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3856023848056793},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/69873","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/69873","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Achtari, C., Fink, D., G\u00fcnthert, A. R., Huober, J., Pestalozzi, B., Petignat, P., von Moos, R., & Sessa, C. (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer \u2013 some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse Du Cancer, 35, 35\u201338.","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-59269","doi":"https://doi.org/10.5167/uzh-59269","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-59269","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"mag:2911758317","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/id/eprint/59269/1/30_Fink_Krebsbulletin.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/69873","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/69873","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Achtari, C., Fink, D., G\u00fcnthert, A. R., Huober, J., Pestalozzi, B., Petignat, P., von Moos, R., & Sessa, C. (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer \u2013 some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse Du Cancer, 35, 35\u201338.","raw_type":"Journal Article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7162066758","https://openalex.org/W4256745541","https://openalex.org/W2995290148","https://openalex.org/W2973386423","https://openalex.org/W2281001378","https://openalex.org/W2135947389","https://openalex.org/W2326109065","https://openalex.org/W2897668906","https://openalex.org/W2911637230","https://openalex.org/W2042861937"],"abstract_inverted_index":{"Adding":[0],"the":[1,67,76,82,95,112,127,133,167,174,178,227,280,287,291,301,313,323,339],"angiogenesis":[2],"inhibitor":[3],"bevacizumab":[4,11,65,99],"to":[5,62,189,224,329],"initial":[6,179],"standard":[7,242,330],"chemotherapy":[8,244,331,342],"followed":[9],"by":[10,37,312],"alone":[12],"as":[13],"maintenance":[14],"therapy":[15],"prolongs":[16],"progression-free":[17],"survival":[18,49,196,205,296],"(PFS)":[19],"time":[20],"significantly":[21],"but":[22],"modestly":[23],"in":[24,66,100,117,126,209,279,294,319],"women":[25,118],"with":[26,98,144,177,192,211,236,300],"advanced":[27,71,246],"epithelial":[28],"ovarian":[29,72,101,149,247],"cancer.":[30,73],"This":[31],"finding":[32],"has":[33,206,297,332],"been":[34,207,298],"reported":[35,208,299],"consistently":[36],"two":[38],"phase":[39],"III":[40,146],"trials,":[41],"GOG-218":[42],"and":[43,90,103,147,157,166,253],"ICON":[44],"7.":[45],"At":[46],"present,":[47],"overall":[48,195,204,295],"(OS)":[50],"data":[51],"are":[52,124],"immature.":[53],"Therefore,":[54],"no":[55,212,237],"recommendation":[56],"can":[57],"be":[58,190],"made":[59],"yet":[60],"how":[61],"best":[63],"incorporate":[64],"front-line":[68],"treatment":[69,266,318],"of":[70,75,81,136,155,184,197,220,272,303,308,315,325],"Members":[74],"gynecological":[77,139],"cancer":[78,102,110,116,150,248],"working":[79],"group":[80],"Swiss":[83],"Group":[84],"for":[85,106,233,245,257,264],"Clinical":[86],"Cancer":[87],"Research":[88],"(SAKK)":[89],"other":[91],"specialists":[92],"have":[93],"discussed":[94],"latest":[96],"findings":[97],"their":[104],"consequences":[105],"clinical":[107],"practice.":[108],"Ovarian":[109],"is":[111,132,170,222,267],"seventh":[113],"most":[114],"frequent":[115],"worldwide":[119],"(1).":[120],"Its":[121],"incidence":[122],"rates":[123],"highest":[125],"western":[128],"world,":[129],"where":[130],"it":[131],"leading":[134],"cause":[135],"death":[137],"from":[138],"malignancies":[140],"(2,":[141],"3).":[142],"Patients":[143],"stage":[145],"IV":[148],"require":[151],"a":[152,163,181,193,201,251,254,304,326],"combined":[153],"approach":[154],"surgery":[156,161,221],"chemotherapy.":[158],"Primary":[159],"debulking":[160],"plays":[162],"key":[164],"role":[165],"final":[168],"outcome":[169],"highly":[171],"dependent":[172],"on":[173],"results":[175],"achieved":[176],"surgery:":[180],"residual":[182,214,239],"tumor":[183,277],">1":[185],"cm":[186],"was":[187],"found":[188],"associated":[191],"median":[194,203],"12\u201316":[198],"months,":[199],"while":[200],"longer":[202],"patients":[210,274,321],"macroscopic":[213,238],"disease":[215],"(4).":[216],"The":[217,241,261],"ultimate":[218],"goal":[219],"cytoreduction":[223,230],"microscopic":[225],"disease,":[226],"term":[228],"optimal":[229],"being":[231],"reserved":[232],"those":[234],"cases":[235],"disease.":[240],"first-line":[243,341],"usually":[249],"contains":[250],"taxane":[252],"platinum":[255],"agent":[256],"six":[258],"cycles":[259],"(5-8).":[260],"response":[262],"rate":[263],"this":[265],"approximately":[268],"75%.":[269],"However,":[270],"65%":[271],"these":[273],"will":[275],"develop":[276],"progression":[278],"first":[281],"three":[282],"years":[283],"after":[284],"diagnosis.":[285],"Over":[286],"past":[288],"ten":[289],"years,":[290],"only":[292],"improvement":[293],"introduction":[302],"dose":[305],"dense":[306],"schedule":[307],"paclitaxel":[309],"(9)":[310],"or":[311],"use":[314],"local":[316],"ip":[317],"selected":[320],"(10);":[322],"addition":[324],"third":[327],"cytotoxic":[328],"not":[333],"showed":[334],"any":[335],"significant":[336],"advantage":[337],"over":[338],"established":[340],"(11,":[343],"12).":[344]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2911758317","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2019-02-21T00:00:00"}
